Immunology
Feature
More data back Guillain-Barré risk with Janssen COVID shot
Observed GBS cases after the Janssen shot were 2 to 3 times greater than expected, based on background rates within 21 and 42 days of vaccination...
Feature
Inflammation and immunity troubles top long-COVID suspect list
“I think that it’s a much more complex picture than just inflammation, or just autoimmunity, or just immune dysregulation,” says expert.
Feature
Long COVID affecting more than one-third of college students, faculty
A new study is unique for evaluating mostly healthy, young adults and for its rare look at long COVID in a university community.
News
FDA wants annual COVID boosters, just like annual flu shots
The booster’s formulation would be selected in June targeting the most threatening COVID-19 strains.
Feature
Highly anticipated HIV vaccine fails in large trial
The vaccine had been in development since 2019 and was given to 3,900 study participants through October 2022.
From the Journals
Scientists use mRNA technology for universal flu vaccine
Two years ago marked a significant moment for messenger RNA (mRNA) technology.
Feature
COVID booster shot poll: People ‘don’t think they need one’
A new poll shows why so few people are willing to get the latest COVID booster.
Feature
As COVID treatments dwindle, are new ones waiting in the wings?
Bebtelovimab couldn’t neutralize the Omicron subvariants BQ.1 and BQ.1.1.
Feature
Have you heard of VEXAS syndrome?
The prevalence of this syndrome is unknown, but it is not so rare.
Feature
Have long COVID? Newest booster vaccines may help you
‘A bivalent booster might actually [help with] your long COVID,’ epidemiologist said.
Latest News
Infant BCG vaccine protects only those under age 5 years
Although infant BCG vaccination is important to young children who are at high risk for tuberculosis, it does not prevent adult-type cavitary...